Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Monday 13th December 2004 Phase II Lecture theatre Corporate Brief 131204 Agenda • Clinical Governance and Developments (Keith Hyde) • People (Pat Zukowskyj) • PFI & Facilities (Pat Zukowskyj) • Finance (Pat Zukowskyj) • Fire Lecture ( Malcolm Dunlop) Corporate Brief 131204 Clinical Governance • Clinical Incidents – SIRT • IM & T – national programme • Pathology Modernisation – Capacity : community Diagnostics – Networks • Quality : CPA Jan 2006 & Service audits • CSB & Immunology Official Openings Corporate Brief 131204 Developments • Liquid based Cytology £500K + 500K (Y Wright) • National Hb Screening £100K (J Ardern) • SHO Training School £100K (C Hall/H Waters) • Better Blood Transfusion (J Ardern) • Infection Control eg Chlamydia £200K +(Professor Bolton) • EQA: Digital imaging (K Hyde/M Desai) • IVF & BNP developments Corporate Brief 131204 People • Consultant Contract (K Hyde) • Agenda for change (P Zukowskyj) • Communications (P Zukowskyj) • Healthcare Scientists (P Zukowskyj) • User Surveys (M Dunlop) Corporate Brief 131204 Facilities • PFI – CSB III Plans Corporate Brief 131204 Finance • Clinical & Scientific Support Services Division Overspent mainly due to extra lists in theatres, to try and get waiting lists down • Laboratory medicine underspent – Variance due mainly to pay – 70% – Rest due to internal recharging for our tests to other Directorate’s, and some external income • Directorates initial share of Divisional CRES target for the year (£80k) has been implemented • Directorate’s progress against our procurement target has yet to be assessed • Finance is the focus of the final Laboratory Managers meeting each month Corporate Brief 131204